Benjamin Smeal's most recent trade in Evoke Pharma Inc was a trade of 1,125 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | Benjamin Smeal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,125 | 6,958 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Benjamin Smeal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) |